ReviewCurrent treatment options in oncology2025

Navigating PARP Inhibitor Resistance in Ovarian Cancer: Bridging Mechanistic Insights To Clinical Translation.

Ziyi Wang et al.PubMed ↗Publisher ↗

No numbers read from the abstract.